Search bioRxiv⌕ Search

Biology subjects

Froehlich, M.

Publications and source records attributed to Froehlich, M..

2 recordsLinked to original sources

Wild-captive contrasts in non-vocal communicative repertoires and functional specificity in orang-utans

The creation of novel communicative acts is an essential element of human language. Although some research suggests the presence of this ability in great apes, this claim remains controversial. Here, we use orang-utans (Pongo spp.) to systematically assess the effect of the wild-captive contrast on the repertoire size of communicative acts. We find that individual communicative repertoires are significantly larger in captive compared to wild settings, irrespective of species, age-sex class or sampling effort. Twenty percent of the orang-utan repertoire in captivity were not observed in the wild. In Sumatran orang-utans, the more sociable species, functional specificity was also higher in captive versus wild settings. We thus conclude that orang-utans, when exposed to a more sociable and terrestrial lifestyle, have the behavioural plasticity to invent new communicative behaviours that are highly functionally specific. This productive capacity by great apes is a major prerequisite for the evolution of language and seems to be ancestral in the hominid lineage.

animal behavior and cognition↗

From COVID-19 to the Common Cold: Novel Host-Targeted, Pan-Respiratory Antiviral Small Molecule Therapeutics

We present a novel small molecule antiviral chemotype that was identified by an unconventional cell-free protein synthesis and assembly-based phenotypic screen for modulation of viral capsid assembly. Activity of PAV-431, a representative compound from the series, has been validated against infectious virus in multiple cell culture models for all six families of viruses causing most respiratory disease in humans. In animals this chemotype has been demonstrated efficacious for Porcine Epidemic Diarrhea Virus (a coronavirus) and Respiratory Syncytial Virus (a paramyxovirus). PAV-431 is shown to bind to the protein 14-3-3, a known allosteric modulator. However, it only appears to target the small subset of 14-3-3 which is present in a dynamic multi-protein complex whose components include proteins implicated in viral lifecycles and in innate immunity. The composition of this target multi-protein complex appears to be modified upon viral infection and largely restored by PAV-431 treatment. Our findings suggest a new paradigm for understanding, and drugging, the host-virus interface, which leads to a new clinical therapeutic strategy for treatment of respiratory viral disease.

biochemistry↗